Cite
HARVARD Citation
Wagner, A. et al. (n.d.). 64. EORTC-1203: Integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER-2 positive stomach cancer: INNOVATION EudraCT number 2014-000722-38; NCT02205047. European journal of surgical oncology. 42 (9), pp. S91-S92. [Online].